FRA:R9Z (China)
Â
Ordinary Shares - Class H
€
0.37
+0.038 (+11.52%)
Aug 11
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Valuation Measures
Fundamental (50)
Valuation Ratio (87)
Profitability (8)
Price (22)
Dividends (7)
Income Statement (47)
Balance Sheet (85)
Cashflow statement (66)